Key Insights

Highlights

Treatment Research

3 treatments under study, led by Cholic Acid

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

100.0%

1 terminated out of 1 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Terminated1

Clinical Trials (1)

Showing 1 of 1 trials
NCT00004442Not ApplicableTerminated

Study of Bile Acids in Patients With Peroxisomal Disorders

Showing all 1 trials

Research Network

Common Treatments

  • Cholic Acid1
  • Chenodeoxycholic Acid1
  • Ursodiol1

Active Sponsors

  • University of Cincinnati1
  • Children's Hospital Medical Center, Cincinnati1

Top Investigators

Related Conditions

  • Zellweger Syndrome1
  • Adrenoleukodystrophy1
  • Infantile Refsums Disease1

Activity Timeline